Cargando…
CD133 Promotes Adhesion to the Ovarian Cancer Metastatic Niche
Cancer stem cells (CSCs) are an attractive therapeutic target due to their predicted role in both metastasis and chemoresistance. One of the most commonly agreed on markers for ovarian CSCs is the cell surface protein CD133. CD133+ ovarian CSCs have increased tumorigenicity, resistance to chemothera...
Autores principales: | Roy, Lynn, Bobbs, Alexander, Sattler, Rachel, Kurkewich, Jeffrey L, Dausinas, Paige B, Nallathamby, Prakash, Cowden Dahl, Karen D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894897/ https://www.ncbi.nlm.nih.gov/pubmed/29662326 http://dx.doi.org/10.1177/1179064418767882 |
Ejemplares similares
-
ARID3B Directly Regulates Ovarian Cancer Promoting Genes
por: Bobbs, Alexander, et al.
Publicado: (2015) -
Emerging and Evolving Ovarian Cancer Animal Models
por: Bobbs, Alexander S, et al.
Publicado: (2015) -
Arid3b Is Critical for B Lymphocyte Development
por: Kurkewich, Jeffrey L., et al.
Publicado: (2016) -
Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?
por: Roy, Lynn, et al.
Publicado: (2018) -
CD133 antigen expression in ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2009)